Skip to main content
Premium Trial:

Request an Annual Quote

Charles Wagner, Anthony Mattachione

Charles Wagner has resigned as executive vice president and CFO at Bruker, effective June 12, in order to become the CFO of Ortho-Clinical Diagnostics. Bruker said that it intends to initiate a search for Wagner's replacement. Anthony Mattacchione, senior vice president of finance and accounting at Bruker, will serve as interim CFO upon Wagner's departure. 

Wagner became CFO of Bruker in 2012. Before that, he was a board member at the company. Prior to joining Bruker, he was CFO of Millipore, now EMD Millipore and part of Merck KGaA. 

The Scan

Omicron's Emergence

The World Health Organization has called Omicron a SARS-CoV-2 "variant of concern," the Los Angeles Times writes.

Not as Much

Merck's pill to treat COVID-19 reduces the risk of hospitalization and death among COVID-19 patients by less than previously reported, the New York Times says.

Bats That Hang Together

Discover magazine writes that researchers have found a social microbiome among vampire bats.

PLOS Papers on CEWAS, Simian Varicella Virus Transcriptome, Dermatomyositis Markers

In PLOS this week: multi-omic approach to home in on genetic risk variants, transcriptomic analysis of the simian varicella virus, and more.